Literature DB >> 20663095

Early onset pneumonia in patients with cholinesterase inhibitor poisoning.

Chen-Yu Wang1, Chieh-Liang Wu, Yu-Tse Tsan, Jeng-Yuan Hsu, Dong-Zong Hung, Chih-Hung Wang.   

Abstract

BACKGROUND AND
OBJECTIVE: Organophosphates and carbamates are potent cholinesterase inhibitors that are widely used as insecticides in agriculture. Pneumonia is a frequent complication of cholinesterase inhibitor poisoning (CIP) and a risk factor for death. The aim of this retrospective study was to assess the risk factors for pneumonia in patients with CIP.
METHODS: The medical records of 155 patients, who were treated for CIP in a 1300-bed medical centre in central Taiwan, from January 2002 to December 2004, were retrospectively analysed. Pneumonia was diagnosed by a new or persistent infiltrate on CXR, as well as clinical symptoms. Demographic data, comorbidities, acute respiratory failure and in-hospital mortality were also recorded.
RESULTS: Of the 155 patients, 31 (20%) died and 92 (59.4%) developed acute respiratory failure. Thirty-four patients (21.9%) were diagnosed with early onset pneumonia during hospitalization. Acute respiratory failure (OR 12.10, 95% CI: 2.55-57.45), underlying cardiovascular disease (OR 3.02, 95% CI: 1.02-8.91), undergoing gastric lavage at peripheral hospitals (OR 6.23, 95% CI: 1.52-25.98) and development of respiratory failure at the study centre after gastric lavage (OR 3.43, 95% CI: 1.17-10.0) were predictive factors for early onset pneumonia. Cardiopulmonary resuscitation (OR 23.58, 95% CI: 6.03-92.29), early onset pneumonia (OR 7.45, 95% CI: 2.02-27.5) and lower Glasgow coma score (OR 1.26, 95% CI: 1.08-1.48) were predictive factors for mortality.
CONCLUSIONS: Pneumonia was a significant risk factor for death in patients with CIP. In addition to aggressive management of patients with CIP who develop respiratory failure, careful respiratory evaluation before and after gastric lavage would help to decrease the incidence of early onset pneumonia in patients with CIP.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20663095     DOI: 10.1111/j.1440-1843.2010.01806.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  10 in total

Review 1.  Organophosphorus Pesticides as Modulating Substances of Inflammation through the Cholinergic Pathway.

Authors:  Milton Rafael Camacho-Pérez; Carlos Eduardo Covantes-Rosales; Gladys Alejandra Toledo-Ibarra; Ulises Mercado-Salgado; María Dolores Ponce-Regalado; Karina Janice Guadalupe Díaz-Resendiz; Manuel Iván Girón-Pérez
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208

2.  Risk of pneumonia in new users of cholinesterase inhibitors for dementia.

Authors:  Edward Chia-Cheng Lai; Monera B Wong; Isao Iwata; Yinghong Zhang; Cheng-Yang Hsieh; Yea-Huei Kao Yang; Soko Setoguchi
Journal:  J Am Geriatr Soc       Date:  2015-04-27       Impact factor: 5.562

Review 3.  Clinical features of organophosphate poisoning: A review of different classification systems and approaches.

Authors:  John Victor Peter; Thomas Isiah Sudarsan; John L Moran
Journal:  Indian J Crit Care Med       Date:  2014-11

4.  One-year mortality among hospital survivors of cholinesterase inhibitor poisoning based on Taiwan National Health Insurance Research Database from 2003 to 2012.

Authors:  Min-Chun Chuang; Chih-Hao Chang; Chung Shu Lee; Shih-Hong Li; Ching-Chung Hsiao; Yueh-Fu Fang; Meng-Jer Hsieh
Journal:  BMC Pharmacol Toxicol       Date:  2018-11-13       Impact factor: 2.483

Review 5.  Immunotoxic role of organophosphates: An unseen risk escalating SARS-CoV-2 pathogenicity.

Authors:  Prem Rajak; Abhratanu Ganguly; Saurabh Sarkar; Moutushi Mandi; Moumita Dutta; Sayanti Podder; Salma Khatun; Sumedha Roy
Journal:  Food Chem Toxicol       Date:  2021-01-23       Impact factor: 6.023

6.  Clinical profile and outcome of acute organophosphate poisoning in children of Upper Egypt: a cross-sectional study.

Authors:  Khaled A Abdel Baseer; Eman Fathala Gad; Yaser F Abdel Raheem
Journal:  BMC Pediatr       Date:  2021-02-26       Impact factor: 2.125

7.  Towards Understanding COVID-19: Molecular Insights, Co-infections, Associated Disorders, and Aging.

Authors:  Elena L Paley
Journal:  J Alzheimers Dis Rep       Date:  2021-07-20

8.  Outcomes of elderly patients with organophosphate intoxication.

Authors:  Jia-Ruei Yu; Yi-Chou Hou; Jen-Fen Fu; I-Kuan Wang; Ming-Jen Chan; Chao-Yu Chen; Cheng-Hao Weng; Wen-Hung Huang; Huang-Yu Yang; Ching-Wei Hsu; Tzung-Hai Yen
Journal:  Sci Rep       Date:  2021-06-02       Impact factor: 4.379

9.  Prognostic Factors in Cholinesterase Inhibitor Poisoning.

Authors:  In O Sun; Hyun Ju Yoon; Kwang Young Lee
Journal:  Med Sci Monit       Date:  2015-09-28

10.  Relative Risk and Clinical Severity Assessment in Patients with Non-Oral Route Organophosphate Poisoning Compared with Oral Route Poisoning.

Authors:  Woo Jin Jung; Min Heui Yu; Yoonsuk Lee; Hyun Kim; Yong Sung Cha; Kyung Hye Park
Journal:  Yonsei Med J       Date:  2018-10       Impact factor: 2.759

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.